MedPath
NMPA Approval

Azithromycin for Suspension

国药准字H20249812

December 25, 2024

Drug Information

阿奇霉素干混悬剂

口服混悬剂

0.1g(按C₃₈H₇₂N₂O₁₂计)

化学药品

December 25, 2024

Company Information

Applicant Company

河南省开封市尉氏县新尉工业园区建业路6号

Manufacturing Company

河南省开封市尉氏县新尉工业园区建业路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿奇霉素干混悬剂 - NMPA 批准文号 | MedPath